Disclose all medications, including GLP-1 agents, your dosing frequency and the date of your last injection, then ask about their specific deferral policy for your medication
A Rise in Kidney Stones in GLP-1 Users and Those with Metabolic Syndrome July 6, 2026 By: Shams Zia MD Categories: Urology Tags: kidney stones, GLP 1, GLP-1 agonist The risk of kidney stone formation continues to rise in the general population, especially since the COVID pandemic
Glucagon-like peptide-1 regulates mitochondrial biogenesis and tau phosphorylation against advanced glycation end product-induced neuronal insult: studies in vivo and in vitro
More and more people are asking how these medications might affect fertility, especially those preparing for IVF or trying to conceive naturally
CJC-1295 is a synthetic GHRH analog built on the first 29 amino acids of GHRH with a Drug Affinity Complex (DAC) lysine modification that enables covalent binding to serum albumin
Calvo Tardn M, Marinari E, Migliorini D, Bes V, Tankov S, Charrier E, et al
